Treace Medical Concepts, Inc.
TMCI
Positions held
Your positionsTMCI isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $252.01M | Enterprise value | $279.44M | Trailing P/E | — | Forward P/E | -4.56 |
| PEG | — | Price / book | 3.72 | Beta | 1.49 | Dividend yield | 0.00% |
| Revenue growth | -4.2% | Earnings growth | — | Gross margin | 79.5% | Operating margin | -33.0% |
| Profit margin | -29.0% | ROE | -72.0% | ROA | -17.3% | Debt / equity | 1.08 |
| Current ratio | 2.90 | Free cash flow | -$6.25M | Analyst recommendation | none | Mean target | $5.50 |
| 52w high | $7.08 | 52w low | $1.17 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $45.4M | $47.2M | $62.5M | $50.2M | $47.4M |
| Op margin | -33.0% | -36.4% | -9.5% | -31.2% | -35.8% |
| Net income | -$15.9M | -$18.0M | -$9.4M | -$16.3M | -$17.4M |
| Gross margin | 78.5% | 79.3% | 80.6% | 79.1% | 79.7% |
| Gross profit | $35.6M | $37.4M | $50.4M | $39.7M | $37.8M |
| Operating income | -$15.0M | -$17.2M | -$5.9M | -$15.7M | -$17.0M |
- Revenue -4% vs prior quarter ($45M vs $47M).
- Gross margin 78.5% (was 79.3% prior quarter).
- Operating margin expanded to -33%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $213M | $209M | $187M | $142M | — |
| Op margin | -25.5% | -26.6% | -27.5% | -24.6% | — |
| Net income | -$59.0M | -$55.7M | -$49.5M | -$42.8M | — |
| Gross margin | 79.8% | 80.4% | 81.2% | 82.0% | — |
| Gross profit | $170M | $168M | $152M | $116M | — |
| Operating income | -$54.2M | -$55.7M | -$51.4M | -$34.8M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-23 · Treace Medical (TMCI) Reports Five-Year Bunion Results. Can Evidence Drive Adoption?
2026-09-17 · Tandem Diabetes Care (TNDM) Soars 7.7%: Is Further Upside Left in the Stock?
2026-08-14 · Treace Medical (TMCI) Q2 2026 Earnings Call Transcript
2026-08-10 · Truist Securities Adjusts PT on Treace Medical Concepts to $5 From $4, Keeps Hold Rating
2026-08-07 · Treace Medical Concepts, Inc. Q2 2026 Earnings Call Summary
2026-08-07 · Treace Medical Concepts Inc (TMCI) (Q2 2026) Earnings Call Highlights: Revenue Declines 4% but ...
2026-08-07 · Treace Medical Concepts Q2 Earnings Call Highlights
2026-08-07 · Treace Medical Concepts (TMCI) Reports Q2 Loss, Tops Revenue Estimates
2026-08-07 · Treace Medical Concepts: Q2 Earnings Snapshot
2026-08-07 · Treace Medical Concepts Reports Second Quarter 2026 Financial Results
Price (daily)
Full chart · RSI · MACD · patterns